Showing 3121-3130 of 4169 results for "".
- Allergan Agrees to Acquire ZELTIQ for $2.47 Billionhttps://modernaesthetics.com/news/allergan-agrees-to-acquire-zeltiq-for-247-billion/2472280/Allergan plc and ZELTIQ® Aesthetics, Inc. have entered into a definitive agreement under which Allergan has agreed to acquire ZELTIQ for $56.50 per share, or $2.475 billion, subject to customary
- Allergan Launches Juvéderm Volitehttps://modernaesthetics.com/news/allergan-launches-juvderm-volite/2472287/Allergan plc launched Juvéderm Volite, an injectable product specifically designed to improve skin quality and last up to nine months with just one treatment session. This innovative new Allergan product uses the unique patented Vycross technology. The new HA injectable treatment d
- Happy 10th Birthday Radiesse!https://modernaesthetics.com/news/happy-10th-birthday-radiesse/2472291/Merz Aesthetics’ flagship brand, Radiesse, turned 10 this year, and was feted in style at a throw-back Thursday media event in New York City. The party took beauty bloggers and journos back to 2007 when the first iPhone was releas
- FDA Approves Restylane Refyne and Restylane Defyne Dermal Fillers for “Laugh Lines”https://modernaesthetics.com/news/fda-approves-restylane-refyne-and-restylane-defyne-dermal-fillers-for-laugh-lines/2472303/The FDA has approved two new Galderma products for the treatment of nasolabial folds (NLF) or “laugh lines,” in patients over the age of 21. Restylane Refyne was approved for the treatment of moderate to severe facial wrinkles and folds and Restylane®
- Jeffrey Dover, MDhttps://modernaesthetics.com/profiles/jeffrey-dover-md/7ZBnXe/
- Jeffrey Dover, MDhttps://modernaesthetics.com/profiles/jeffrey-dover-md/jPKY04/
- Jeffrey Spiegel, MDhttps://modernaesthetics.com/profiles/jeffrey-spiegel-md/OWGM5q/
- Jeffrey Hsuhttps://modernaesthetics.com/profiles/jeffrey-hsu/Oww53G/
- Jeffrey Cohenhttps://modernaesthetics.com/profiles/jeffrey-cohen/OKAN45/
- Jeffrey Cohenhttps://modernaesthetics.com/profiles/jeffrey-cohen/L6d3JE/